-+ 0.00%
-+ 0.00%
-+ 0.00%

ADAR1 Capital Management Reports Acquisition of $1,434.84 in InMed Pharmaceuticals Common Shares

PUBT·10/20/2026 21:32:01
Listen to the news
ADAR1 Capital Management Reports Acquisition of $1,434.84 in InMed Pharmaceuticals Common Shares
  • ADAR1 Capital Management purchased 1,087 InMed Pharmaceuticals common shares at $1.32 each.
  • Indirect beneficial ownership rose to 956,580 common shares.
  • Daniel Schneeberger, ADAR1's manager, is also listed as a 10% owner.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000026), on October 20, 2026, and is solely responsible for the information contained therein.